LIFR and cancer: Additionally, miR-9 stimulates breast tumor cell migration and metastasis by straightforwardly affecting LIFR, which reduces YAP1 activity,77 whereas miR-9-3p serves as a cancer repressor in hepatocellular carcinoma via targeting TAZ, which stimulates cell proliferation78 (Fig. 3).